EMA business hours over Ascension Day holidays, 14 and 15 May
Submitted by Anonymous (not verified) on 12 May 2026 - 13:00
EMA business hours over Ascension Day holidays, 14 and 15 May
Article 57 product data
Submitted by Anonymous (not verified) on 12 May 2026 - 12:12
Article 57 product data
Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)
Submitted by Anonymous (not verified) on 12 May 2026 - 12:04
Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 12:00
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Authorised
PSUSA/00002540/202509
Submitted by Anonymous (not verified) on 12 May 2026 - 10:30
PSUSA/00002540/202509
Veterinary medicines European public assessment report (EPAR): AviGate S. Infantis, Salmonella Infantis vaccine (live), Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 10:10
Veterinary medicines European public assessment report (EPAR): AviGate S. Infantis, Salmonella Infantis vaccine (live), Status: Authorised
Veterinary medicines European public assessment report (EPAR): VeroBlue-3, bluetongue virus vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 10:10
Veterinary medicines European public assessment report (EPAR): VeroBlue-3, bluetongue virus vaccine (inactivated), Status: Authorised
EMA welcomes political agreement on Critical Medicines Act
Submitted by Anonymous (not verified) on 12 May 2026 - 9:16
EMA welcomes political agreement on Critical Medicines Act
Template for response to list of questions/list of outstanding issues: Quality / Non-clinical / Clinical
Submitted by Anonymous (not verified) on 12 May 2026 - 8:10
Template for response to list of questions/list of outstanding issues: Quality / Non-clinical / Clinical
Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 11 May 2026 - 16:11
Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 25, Status: Authorised